1AI — Algorae Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- AU$8.44m
- AU$6.03m
- AU$0.13m
Annual cashflow statement for Algorae Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | R2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.117 | 0.023 | 0.002 | 0.033 | 0.107 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.11 | -1.46 | -2.04 | -1.99 | -1.52 |
| Capital Expenditures | 0 | — | -0.004 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.24 | 0.106 | 0.043 | 0.978 | -0.277 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 1.24 | 0.106 | 0.04 | 0.978 | -0.277 |
| Financing Cash Flow Items | — | — | 1.83 | -0.299 | -0.049 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.05 | -0.045 | 4.69 | 1.85 | 0.523 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.94 | -1.4 | 2.67 | 0.85 | -1.28 |